Regulatory Focus: FDA Delays Release of Several Proposed Rulemakings
The Regulatory Affairs Professionals Society (RAPS) reports that the US Food and Drug Administration (FDA) has released its latest regulatory agenda announcing the delays of several proposed rulemakings, including its proposed rulemaking on excluding certain medical software functions from the definition of a device until next May. The agency previously said the proposed rule was coming in December.
